Clinical Trial Update: Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer

View source ↗

Summary

A terminated clinical trial update evaluating concordance of actionable genomic alterations between tumor tissue and plasma in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Genomic Health®, Inc. | Conditions: Non Small Cell Lung Carcinoma | Status: TERMINATED | Results posted: 2019-11-25